Australia markets closed

Sino Biopharmaceutical Limited (SBMFF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.31490.0000 (0.00%)
At close: 09:47AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.89B
Enterprise value 6.68B
Trailing P/E 22.34
Forward P/E 18.08
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.62
Price/book (mrq)1.41
Enterprise value/revenue 0.26
Enterprise value/EBITDA 0.96

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-41.67%
S&P500 52-week change 322.38%
52-week high 30.5400
52-week low 30.3149
50-day moving average 30.3580
200-day moving average 30.3834

Share statistics

Avg vol (3-month) 3870
Avg vol (10-day) 350
Shares outstanding 518.79B
Implied shares outstanding 621.91B
Float 89.28B
% held by insiders 148.19%
% held by institutions 115.69%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.01
Forward annual dividend yield 42.03%
Trailing annual dividend rate 30.05
Trailing annual dividend yield 314.29%
5-year average dividend yield 41.47
Payout ratio 472.63%
Dividend date 315 Dec 2017
Ex-dividend date 411 June 2024
Last split factor 23:2
Last split date 304 June 2018

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 8.90%
Operating margin (ttm)20.76%

Management effectiveness

Return on assets (ttm)5.33%
Return on equity (ttm)12.12%

Income statement

Revenue (ttm)26.2B
Revenue per share (ttm)1.41
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 6.38B
Net income avi to common (ttm)1.85B
Diluted EPS (ttm)0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.12B
Total cash per share (mrq)0.77
Total debt (mrq)12.72B
Total debt/equity (mrq)33.31%
Current ratio (mrq)1.05
Book value per share (mrq)1.66

Cash flow statement

Operating cash flow (ttm)6.07B
Levered free cash flow (ttm)3.01B